Streamlining Rare Disease Drug Development

EP: 1.The Benefits of Working with mRNA for Therapeutics

EP: 2.Public Perception and Communicating the Potential and Safety of mRNA

EP: 3.Lessons from Vaccine Development and Future Possibilities

Now Viewing

EP: 4.Streamlining Rare Disease Drug Development

EP: 5.Navigating Challenges and Embracing Opportunities to Optimize mRNA Therapies

EP: 6.Overcoming Delivery Challenges of mRNA Therapeutics

EP: 7.The Future of Manufacturing, Safety, and Collaboration

EP: 8.Key Takeaways from the Peer Exchange Discussion “Aligning mRNA Progress with Regulatory Streamlining”

The conversation centered around the potential of mRNA technology for therapeutic development, with a focus on project management, meeting efficiency, and the challenges of mRNA production.

Discussion Topics

• 00:00 - Core aspects of CMC for mRNA as a shared platform for cGMP compliance
• 2:17 - Adapting mRNA manufacturing processes to quickly produce vaccine variants
• 5:18 - Differences in quality and purity of mRNA products from various manufacturers
• 6:12 - Developing guidelines to accelerate rare disease drug development, similar to Operation Warp Speed